Cilofexor, a Nonsteroidal FXR Agonist, in Patients With Noncirrhotic NASH: A Phase 2 Randomized Controlled Trial

Keyur Patel, Stephen A. Harrison, Magdy Elkhashab, James F. Trotter, Robert Herring, Sergio E. Rojter, Zeid Kayali, Vincent Wai‐Sun Wong, Susan Greenbloom, Saumya Jayakumar, Mitchell L. Shiffman, Bradley Freilich, Eric J. Lawitz, Edward J. Gane, Eliza Harting, Jun Xu, Andrew N. Billin, Chuhan Chung, C. Stephen Djedjos, G. Mani Subramanian, Robert P. Myers, Michael S. Middleton, Mary Rinella, Mazen Noureddin – 1 March 2020

Cilofexor, a Nonsteroidal FXR Agonist, in Patients With Noncirrhotic NASH: A Phase 2 Randomized Controlled Trial

Keyur Patel, Stephen A. Harrison, Magdy Elkhashab, James F. Trotter, Robert Herring, Sergio E. Rojter, Zeid Kayali, Vincent Wai‐Sun Wong, Susan Greenbloom, Saumya Jayakumar, Mitchell L. Shiffman, Bradley Freilich, Eric J. Lawitz, Edward J. Gane, Eliza Harting, Jun Xu, Andrew N. Billin, Chuhan Chung, C. Stephen Djedjos, G. Mani Subramanian, Robert P. Myers, Michael S. Middleton, Mary Rinella, Mazen Noureddin – 1 March 2020

Subscribe to